Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Fava, Carmen
[Clear All Filters]
2023
Tiribelli M
,
Latagliata R
,
Breccia M
,
Capodanno I
,
Miggiano MCristina
,
Cavazzini F
,
Bucelli C
,
Attolico I
,
Crescenzi SLeonetti
,
Russo S
, et al.
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.
Cancer. 2023.
PubMed
Google Scholar
Pacelli P
,
Santoni A
,
Sicuranza A
,
Abruzzese E
,
Giai V
,
Crugnola M
,
Annunziata M
,
Galimberti S
,
Iurlo A
,
Luciano L
, et al.
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26 leukemia stem cells.
Front Pharmacol. 2023;14:1194712.
PubMed
Google Scholar
2016
Iurlo A
,
Nobili A
,
Latagliata R
,
Bucelli C
,
Castagnetti F
,
Breccia M
,
Abruzzese E
,
Cattaneo D
,
Fava C
,
Ferrero D
, et al.
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome.
Oncotarget. 2016.
PubMed
Google Scholar
2015
Fava C
,
Morotti A
,
Dogliotti I
,
Saglio G
,
Rege-Cambrin G
.
Update on emerging treatments for chronic myeloid leukemia.
Expert Opin Emerg Drugs. 2015:1-14.
PubMed
Google Scholar
2013
Russo D
,
Martinelli G
,
Malagola M
,
Skert C
,
Soverini S
,
Iacobucci I
,
De Vivo A
,
Testoni N
,
Castagnetti F
,
Gugliotta G
, et al.
Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia.
Blood. 2013.
PubMed
Google Scholar